Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Gastroenterology. 2020 Feb 29;158(8):2082–2092. doi: 10.1053/j.gastro.2020.02.037

Figure 2. Receiver Operating Characteristics Curves for (2a) Discriminating Barrett’s Esophagus among First EGD Subjects and (2b) Early Neoplastic Barrett’s Esophagus from No Barrett’s Esophagus.

Figure 2.

Area under the receiver operating characteristics curves in parentheses. Note that Locke relies on current PPI use and early neoplastic Barrett’s esophagus patients were prescribed PPI in anticipation of endoscopic therapy, so Locke was not evaluated in the analysis for early neoplastic Barrett’s esophagus.